Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study

Background: Both sodium glucose cotransporter 2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular protective effects in patients with type 2 diabetes mellitus. However, the comparative risk of GLP-1RA versus SGLT-2i for major adverse limb events remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yen-Chieh, Dong, Yaa-Hui, Yang, Wei-Shun, Wu, Li-Chiu, Lin, Jou-Wei, Chang, Chia-Hsuin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513310/
https://www.ncbi.nlm.nih.gov/pubmed/36176438
http://dx.doi.org/10.3389/fphar.2022.869804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513310/
https://www.ncbi.nlm.nih.gov/pubmed/36176438
http://dx.doi.org/10.3389/fphar.2022.869804

Ejemplares similares